Response to cardiac resynchronization therapy: Is it time to expand the criteria?

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 10, 2009, Pages 1247-1256

  Versteeg, Henneke ^a   Schiffer, Angélique A ^b   Widdershoven, Jos W ^b   Meine, Mathias M ^c   Doevendans, Pieter A ^c   Pedersen, Susanne S ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiac resynchronization therapy; Health status; NYHA class; Psychological factors; Response; Viewpoint

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ANAMNESIS; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEMODYNAMIC PARAMETERS; HUMAN; OXYGEN CONSUMPTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW;

CARDIAC PACING, ARTIFICIAL; HEALTH STATUS INDICATORS; HEART FAILURE; HUMANS; INCIDENCE; OUTCOME ASSESSMENT (HEALTH CARE); TREATMENT OUTCOME;

EID: 70349683017     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02505.x     Document Type: Review

References (76)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008 29 : 2388 2442.
2. van Kraaij DJW, van Pol PEJ, Ruiters AW, de Swart JBRM, Lips DJ, Lencer N, Doevendans PAFM. Diagnosing diastolic heart failure. Eur J Heart Fail 2002 4 : 419 430.
3. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005 46 : e1 82.
4. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics - 2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007 115 : e69 171.
5. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 2008 52 : 428 434.
6. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002 346 : 1845 1853.
7. Beshai JF, Grimm RA, Nagueh SF, Baker JH, Beau SL, Greenberg SM, Pires LA, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007 357 : 2461 2471.
8. Littmann L, Symanski JD. Hemodynamic implications of left bundle branch block. J Electrocardiol 2000 33 (Suppl 115 121.
9. Leclercq C, Kass DA. Retiming the failing heart: Principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002 39 : 194 201.
10. Nelson GS, Curry CW, Wyman BT, Kramer A, Declerck J, Talbot M, Douglas MR, et al. Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation 2000 101 : 2703 2709.
11. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 : 2140 2150.
12. Albouaini K, Egred M, Rao A, Alahmar A, Wright DJ. Cardiac resynchronisation therapy: Evidence based benefits and patient selection. Eur J Intern Med 2008 19 : 165 172.
13. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: A systematic review. JAMA 2007 297 : 2502 2514. (Pubitemid 46953404)
14. Bilchick KC, Lardo AC. Cardiac resynchronization therapy: Application of imaging to optimize patient selection and assess response. Curr Heart Fail Rep 2008 5 : 119 127.
15. Reuter S, Garrigue S, Barold SS, Jais P, Hocini M, Haissaguerre M, Clementy J. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 2002 89 : 346 350.
16. Chung ES, Leon AR, Tavazzi L, Sun J-P, Nihoyannopoulos P, Merlino J, Abraham WT, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008 117 : 2608 2616.
17. De Boeck BWL, Meine M, Leenders GE, Teske AJ, van Wessel H, Kirkels JH, Prinzen FW, et al. Practical and conceptual limitations of tissue Doppler imaging to predict reverse remodelling in cardiac resynchronisation therapy. Eur J Heart Fail 2008 10 : 281 290.
18. Lellouche N, De Diego C, Cesario DA, Vaseghi M, Horowitz BN, Mahajan A, Wiener I, et al. Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy. Am J Cardiol 2007 99 : 242 246.
19. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001 344 : 873 880.
20. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002 39 : 2026 2033. (Pubitemid 34628286)
21. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR, Böcker D, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003 42 : 2109 2116.
22. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 : 1539 1549. (Pubitemid 40517094)
23. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003 42 : 1454 1459.
24. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003 289 : 2685 2694.
25. Food and Drugs Administration. Summary of safety and effectiveness: St. Jude Medical Epic 4 Hf system including the Epic HF model V-338 cardiac resynchronization therapy defibrillator, the Aescula LV model 1055K lead, the QuickSite TM LV model 1056K lead, and the model 3307 v4.5m programmer software [P030054]. FDA, 2005. http://www.fda.gov/cdrh/pdf3/P030054b.pdf
26. Stanek EJ, Oates MB, McGhan WF, Denofrio D, Loh E. Preferences for treatment outcomes in patients with heart failure: Symptoms versus survival. J Card Fail 2000 6 : 225 232.
27. Ekman I, Cleland JGF, Andersson B, Swedberg K. Exploring symptoms in chronic heart failure. Eur J Heart Fail 2005 7 : 699 703.
28. Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J 2002 23 : 1861 1866.
29. Bettencourt P, Ferreira A, Dias P, Pimenta J, Friões F, Martins L, Cerqueira-Gomes M. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail 2000 6 : 306 313.
30. Kubo SH, Schulman S, Starling RC, Jessup M, Wentworth D, Burkhoff D. Development and validation of a patient questionnaire to determine New York Heart Association classification. J Card Fail 2004 10 : 228 235.
31. Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R, Mayet J, et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 2007 93 : 476 482.
32. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: Advantages of a new specific activity scale. Circulation 1981 64 : 1227 1234.
33. Goode KM, Nabb S, Cleland JGF, Clark AL. A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic. J Card Fail 2008 14 : 379 387.
34. Majani G, Pierobon A, Giardini A, Callegari S, Opasich C, Cobelli F, Tavazzi L. Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity. Eur Heart J 1999 20 : 1579 1586.
35. Grigioni F, Carigi S, Grandi S, Potena L, Coccolo F, Bacchi-Reggiani L, Magnani G, et al. Distance between patients' subjective perceptions and objectively evaluated disease severity in chronic heart failure. Psychother Psychosom 2003 72 : 166 170.
36. Subramanian U, Weiner M, Gradus-Pizlo I, Wu J, Tu W, Murray MD. Patient perception and provider assessment of severity of heart failure as predictors of hospitalization. Heart Lung 2005 34 : 89 98.
37. Moons P, Van Deyk K, De Geest S, Gewillig M, Budts W. Is the severity of congenital heart disease associated with the quality of life and perceived health of adult patients? Heart 2005 91 : 1193 1198.
38. Ganiats TG, Browner DK, Dittrich HC. Comparison of quality of well-being scale and NYHA functional status classification in patients with atrial fibrillation. New York Heart Association. Am Heart J 1998 135 : 819 824.
39. Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, Haass M. Health related quality of life in patients with congestive heart failure: Comparison with other chronic diseases and relation to functional variables. Heart 2002 87 : 235 241.
40. Bennett JA, Riegel B, Bittner V, Nichols J. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung 2002 31 : 262 270.
41. Bosworth HB, Steinhauser KE, Orr M, Lindquist JH, Grambow SC, Oddone EZ. Congestive heart failure patients' perceptions of quality of life: The integration of physical and psychosocial factors. Aging Ment Health 2004 8 : 83 91.
42. Hobbs FDR, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002 23 : 1867 1876.
43. Ekman I, Cleland JGF, Swedberg K, Charlesworth A, Metra M, Poole-Wilson PA. Symptoms in patients with heart failure are prognostic predictors: Insights from COMET. J Card Fail 2005 11 : 288 292.
44. Mommersteeg P, Denollet J, Spertus JA, Pedersen SS. Health status as a risk factor in cardiovascular disease: A systematic review of current evidence. Am Heart J 2009 157 : 208 218.
45. Uretsky BF, Thygesen K, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: Results of the CARE-HF trial. J Card Fail 2008 14 : 670 675.
46. Garin O, Ferrer M, Pont A, Rué M, Kotzeva A, Wiklund I, Van Ganse E, et al. Disease-specific health-relates quality of life questionnaires for heart failure: A systematic review with meta-analyses. Qual Life Res 2009 18 : 71 85.
47. Spertus J, Peterson E, Vonard MW, Heidenreich PA, Krumholz HM, Jones P, McCullough PA. Monitoring clinical changes in patients with heart failure: A comparison of methods. Am Heart J 2005 150 : 707 715.
48. Spertus JA. Evolving applications for patient-centered health status measures. Circulation 2008 118 : 2103 2110.
49. Van Hemel NM. A review of factors contributing to health related quality of life achieved with cardiac resynchronization therapy for heart failure. Minerva Cardioangiol 2007 55 : 783 802.
50. Shah MR, Hasselblad V, Stinnett SS, Kramer JM, Grossman S, Gheorghiade M, Adams KF, et al. Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure. Eur J Heart Fail 2002 4 : 297 304.
51. Pires LA, Abraham WT, Young JB, Johnson KM. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: Results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Am Heart J 2006 151 : 837 843.
52. Abdelhadi R, Adelstein E, Voigt A, Gorcsan J, Saba S. Measures of left ventricular dyssynchrony and the correlation to clinical and echocardiographic response after cardiac resynchronization therapy. Am J Cardiol 2008 102 : 598 601.
53. Bleeker GB, Bax JJ, Fung JW-H, Van Der Wall EE, Zhang Q, Schalij MJ, Chan JY-S, et al. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol 2006 97 : 260 263.
54. Tada H, Toide H, Okaniwa H, Higuchi R, Nakajima T, Utsugi R, Hashimoto T, et al. Maximum ventricular dyssynchrony predicts clinical improvement and reverse remodeling during cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007 30 : S13 S18.
55. Ypenburg C, Roes SD, Bleeker GB, Kaandorp TAM, de Roos A, Schalij MJ, Van Der Wall EE, et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol 2007 99 : 657 660.
56. Singh JP, Fan D, Heist EK, Alabiad CR, Taub C, Reddy V, Mansour M, et al. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm 2006 3 : 1285 1292.
57. Schiffer AlA, Denollet J, Pedersen SS, Broers H, Widdershoven JW. Health status in patients treated with cardiac resynchronization therapy: Modulating effects of personality. Pacing Clin Electrophysiol 2008 31 : 28 37.
58. Schiffer AlA, Denollet J, Widdershoven JW, Hendriks EH, Smith ORF. Failure to consult for symptoms of heart failure in patients with a type-D personality. Heart 2007 93 : 814 818. (Pubitemid 46998979)
59. Denollet J, Vaes J, Brutsaert DL. Inadequate response to treatment in coronary heart disease: Adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation 2000 102 : 630 635.
60. Pedersen SS, van Domburg RT, Theuns DAMJ, Jordaens L, Erdman RAM. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med 2004 66 : 714 719.
61. Pedersen SS, Theuns DAMJ, Muskens-Heemskerk A, Erdman RAM, Jordaens L. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation. Europace 2007 9 : 675 680.
62. Aquarius AE, Denollet J, Hamming JF, De Vries J. Role of disease status and type D personality in outcomes in patients with peripheral arterial disease. Am J Cardiol 2005 96 : 996 1001.
63. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006 48 : 1527 1537.
64. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, Krumholz HM, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003 42 : 1811 1817.
65. Lett H, Ali S, Whooley M. Depression and cardiac function in patients with stable coronary heart disease: Findings from the Heart and Soul Study. Psychosom Med 2008 70 : 444 449.
66. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: The Heart and Soul Study. JAMA 2003 290 : 215 221.
67. Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB. Depression and coronary heart disease: Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation 2008 118 : 1768 1775.
68. Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, Mitchell AJ, Zuidersma M. Depression screening and patients outcomes in cardiovascular care. A systematic review. JAMA 2008 300 : 2161 2171.
69. Rohrbaugh MJ, Shoham V, Coyne JC. Effect of marital quality on eight-year survival of patients with heart failure. Am J Cardiol 2006 98 : 1069 1072.
70. Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J 2006 152 : 940.e1 940.e8.
71. MacMahon KMA, Lip GYH. Psychological factors in heart failure: A review of the literature. Arch Intern Med 2002 162 : 509 516.
72. Spertus JA, Eagle KA, Krumholz HM, Mitchell KR, Normand S-LT. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol 2005 45 : 1147 1156.
73. Krumholz HM, Peterson ED, Ayanian JZ, Chin MH, DeBusk RF, Goldman L, Kiefe CI, et al. Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 2005 111 : 3158 3166.
74. Rector T, Kubo SH, Cohn J. Patient's self assessment of their congestive heart failure: Content, reliability, and validity of a new measure: The Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987 3 : 198 219.
75. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure. J Am Coll Cardiol 2000 35 : 1245 1255.
76. Denollet J. DS14: Standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005 67 : 89 97.